急性下壁心肌梗死合并及不合并右室梗死溶栓疗效分析  

Efficacy of thromblytic therapy in patients with acute inferior myocardial infarction with or without right ventricular involvement

作　　者：贾佳[1] 樊琨[1] 耿聆[1] 

机构地区：[1]北京急救中心,北京100031

出　　处：《心血管康复医学杂志》2001年第4期312-314,共3页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：目的 :确定急性下壁心肌梗死 (AIMI)合并或不合并右室梗死 (RVI)患者溶栓治疗的价值。方法 :2 6 5例 AIMI患者中 43例合并 RVI,分为 组 (AIMI组 )及 组 (AIMI+RVI组 ) ,分别就是否接受溶栓治疗 ,住院期间死亡率及并发症发生率进行对比观察。结果 :(1) 组合并高血压、糖尿病者多于 组 ,其中糖尿病差异具极显著意义(P<0 .0 1) ;(2 ) 2 6 3例 AIMI中接受溶栓治疗的 140例、未接受溶栓治疗的 12 5例的住院死亡率分别是 11.4%、2 1.6 % (P<0 .0 5 ) ;(3) 、 组用溶栓治疗时病死率分别为 11.2 %、 12 .5 % ,无显著差异 ;未用溶栓治疗时病死率 17.9%、 42 .1% (P<0 .0 5 )。结论 :AIMI组溶栓治疗住院期间死亡率较非溶栓治疗组的明显降低 ;AIMI+RVI溶栓较单纯 AIMI溶栓治疗益处更为显著。Objective:To determine value of thrombolytic therapy in patients with acute inferior myocardial infarction(AIMI) with or without right ventricular involvement(RVI).Methods:Two hundred and sixty\|five patients were divided into 2 groups:group Ⅰ(AIMI patient without RVI,222 cases),group Ⅱ(AIMI patient with RVI,43 cases).Results:(1)Both hypertension and diabetes in group Ⅱ were more than those of group Ⅰ,among of them,cases of diabetes had extreme significant difference (P<001);(2)Mortality in\|hospital was lower(114%) in 140 patients received thrombolytic therapy,compared with 125 patients received no thrombolytic therapy(216%),P<005;(3)Mortality of group Ⅰ?Ⅱ patients with received thrombolytic therapy were 112%?125% respectively(P>005),but mortality of group Ⅰ?Ⅱ patients with received no thrombolytic therapy were 179%?421% respectively(P<005).Conclusion:Mortality of AIMI patients with received thrombolytic therapy is lower than that of not received thrombolytic therapy;AIMI patient with RVI may gain more benefits from thrombolytic therapy.

关 键 词：溶栓疗法 心肌梗死 急性右室梗死 预后 

分 类 号：R542.22[医药卫生—心血管疾病]